Pharmacy Benefit Managers’ Attack on Physician Dispensing and Impact on Patient Care; Case Study of CVS Caremark’s Efforts to Restrict Access to Cancer Care: This whitepaper was supported in part by UroGPO and is a direct exploitation of the efforts of CVS Caremark to prevent physicians from providing appropriate and economical care to their patients. (http://www.communityoncology.org/wp-content/uploads/2016/08/PBMs_Physician_Dispensing-WhitePaper_COA_FL.pdf)

Defining Deliverables of PCa Fusion-Targeted Biopsy: In this article, published in Renal and Urology News, the authors describe proposed metrics to quantify and compare deliverables of targeted biopsy technologies. (source: http://www.renalandurologynews.com/prostate-cancer/defining-deliverables-pca-fusion-targeted-biopsy/article/525443/)